Browsing by Author "Vernet-Tomás, Maria"

Sort by: Order: Results:

  • Thekkinkattil, Dinesh; Vernet-Tomás, Maria; Dietz, Jill (ecancer, 2022)
    Background: breast cancer is the most common cancer in women worldwide with an estimated 2.3 million breast cancer cases diagnosed annually. The outcome of breast cancer management varies widely across the globe which could ...
  • Posso, Margarita; Corominas Torres, Josep Maria; Serrano, Laia; Román, Marta; Torá Rocamora, Isabel, 1979-; Domingo, Laia; Romero, Anabel; Quintana, María Jesús; Vernet-Tomás, Maria; Baré, Marisa; Vidal, Carmen; Sánchez, Mar; Saladié, Francina; Natal, Carmen; Ferrer, Joana; Servitja Tormo, Sonia; Sala, Maria; Castells, Xavier; BELE Study Group (Wiley, 2017)
    Women with benign breast diseases (BBD) have a high risk of breast cancer. However, no biomarkers have been clearly established to predict cancer in these women. Our aim was to explore whether estrogen receptor (ER), ...
  • Román, Marta; Caicoya, Martin; Espinàs, Josep Alfons; Sala Serra, Maria; Torá Rocamora, Isabel, 1979-; Quinta, Maria J.; Vernet-Tomás, Maria; Saladié, Francina; Romero, Anabel; Sánchez, Mar; Baré, Marisa; Vidal, Carmen; Servitja Tormo, Sonia; Natal, Carmen; Corominas Torres, Josep Maria; Ferrer, Joana; Rodríguez Arana, Ana Maria; Castells, Xavier; BELE Study Group (Wiley-Blackwell, 2018)
    Women with a benign breast disease (BBD) have an increased risk of subsequent breast carcinoma. Information is scarce regarding the characteristics of breast carcinomas diagnosed after a BBD. Our aim was to point out the ...
  • Louro, Javier; Román, Marta; Posso, Margarita; Vázquez‐de las Heras, Ivonne; Saladié, Francina; Rodríguez Arana, Ana Maria; Quintana, María Jesús; Domingo Torrell, Laia; Baré, Marisa; Marcos-Gragera, Rafael; Vernet-Tomás, Maria; Sala, Maria; Castells, Xavier; BELE Study Group; IRIS Study Group; IRIS Study Group (Public Library of Science (PLoS), 2021)
    Background: Several studies have proposed personalized strategies based on women's individual breast cancer risk to improve the effectiveness of breast cancer screening. We designed and internally validated an individualized ...
  • Vernet-Tomás, Maria; Mena, Marisa; Alemany, Laia; Bravo, Ignacio G.; Sanjosé Llongueras, Silvia de; Nicolau, Pau; Bergueiro Flor, Alba; Corominas Torres, Josep Maria; Serrano Figueras, Sergi; Carreras Collado, Ramón; Lloveras Rubio, Belen (International Institute of Anticancer Research , 2015)
    BACKGROUND/AIM: Great controversy exists about the association between Human Papillomavirus (HPV) and breast tumors. The aim of this study was to explore the presence of HPV DNA in a large set of breast cancer cases. ...
  • Nicolau, Pau; Gamero García, Rocío; Rodríguez Arana, Ana Maria; Plancarte Zapata, Francisco; Alcántara da Silva, Rodrigo; Carreras Collado, Ramón; Sabadell Marcadal, Maria Dolores; Vernet-Tomás, Maria (Wiley, 2018)
    AIM: We investigated if imaging and pathology features could help to identify a high axillary tumor burden (ATB) in breast cancer patients, in order to individualize decisions on axillary lymph node (ALN) dissection (ALND). ...
  • Zarcos-Pedrinaci, Irene; Redondo, Maximino; Louro, Javier; Rivas Ruiz, Francisco; Téllez, Teresa; Pérez, Diego; Medina Cano, Francisco; Machan, Kenza; Domingo, Laia; Vernet-Tomás, Maria; Padilla-Ruiz, Maria; Castells, Xavier; Rueda, Antonio; Sala Serra, Maria; REDISSEC-CaMISS Group (Wiley, 2019)
    The aim of this study is to determine the survival of patients with breast cancer treated with adjuvant chemotherapy (ACh) after the diagnosis by screening, taking comorbidity into account. This multicenter cohort study ...
  • García- Aranda, Marilina; Redondo, Maximino; Zarcos-Pedrinaci, Irene; Louro, Javier; Rivas Ruiz, Francisco; Téllez, Teresa; Pérez, Diego; Medina Cano, Francisco; Machan, Kenza; Domingo Torrell, Laia; Vernet-Tomás, Maria; Padilla-Ruiz, Maria; Castells, Xavier; Sala, Maria (Galenos Publishing House, 2022)
    Objective: the aim of this study was to evaluate the existing survival rate and clinical-pathological differences among patients with breast cancer detected by mammographic screening. Materials and methods: this multicenter ...
  • Li, X.; Sanz, Javier; Argudo Aguirre, Nuria; Vernet-Tomás, Maria; Rodríguez de Dios, Núria; Torrent, L.; Fernández-Velilla, E.; Pera-Cegarra, Oscar; Huang, Yan; Nicolau, Pau; Jiménez Gómez, Marta; Segura, M.; Algara López, Manuel-Ignacio (Springer, 2022)
    Purpose: To present the first results of intraoperative irradiation (IORT) in breast cancer with a low-energy photon system used as partial breast irradiation (PBI) or as an anticipated boost before whole breast hypo-fractionated ...
  • Vernet-Tomás, Maria; Baños, Núria; Sabadell Marcadal, Maria Dolores; Corominas Torres, Josep Maria; Mestre-Fusco, Antoni; Suárez-Piñera, Marina; Carreras Collado, Ramón (Wiley, 2015)
    AIM: Several predictive tools of non-sentinel lymph nodes neoplastic involvement when a positive sentinel lymph node is found have been described. However, molecular factors have been rarely evaluated to build these tools. ...
  • Politi, Julieta; Sala Serra, Maria; Domingo Torrell, Laia; Vernet-Tomás, Maria; Román, Marta; Macià Guilà, Francesc Assís; Castells, Xavier (SAGE Publications, 2020)
    Objective: Population-wide mammographic screening programs aim to reduce breast cancer mortality. However, a broad view of the harms and benefits of these programs is necessary to favor informed decisions, especially in ...
  • Vernet-Tomás, Maria; Louro, Javier; Román, Marta; Saladié, Francina; Posso, Margarita; Prieto, Miguel; Vázquez, Ivonne; Baré, Marisa; Peñalva, Lupe; Vidal, Carmen; Bargalló Castelló, Xavier; Sánchez, Mar; Ferrer, Joana; Espinàs, Josep Alfons; Quintana, María Jesús; Rodríguez Arana, Ana Maria; Castells, Xavier; BELE Study Group (Elsevier, 2021)
    Objective: We aimed to explore whether the type of mammographic feature prompting a false-positive recall (FPR) during mammography screening influences the risk and timing of breast cancer diagnosis, particularly if assessed ...